The logo of Gentaur The logo of Gentaur

Treatment of Multidrug Resistance

In order to limit the development of antimicrobial resistance, the following is assumed:

A Graph representing the cases of Acinetobacter resistance according to the National Healht care Safety Network in USA

      Medical community is dependent on the training of the doctors and self-regulation in the form of a complaint to the voluntary use of antimicrobial agents in the hospital that can take the form of an antimicrobial stewardship program. It is depending on the cultural context, it is claimed that it will help to educate the public about the importance of limiting the use of antibiotics for clinical use in humans, and can be, but unlike drugs Te, anywhere in the world, there is no regulation without its use at this time.

      For example, you can limit the treatment of animals for human consumption success, use of antibiotics, are regulated in Denmark. Prevention is the most effective strategies to prevent infection by MDR organisms in the hospital, the wider the case of antibiotic panresistant infection resistance, if it is cut or removed infected or localized, several alternatives (you may attempt to with MDR-TB, but for example there, in the case of systemic infection, lung cancer,) is also possible measures generally used to increase the immune system in the immunoglobulin such. The clinical application at this time (virus kill bacteria) use of bacteriophage.

a graph showing the dwindling number of new antibiotics for the last 30 years according to the National Healht care Safety Network in USA

      Drug-resistant and multidrug resistance tuberculosis and have a high mortality rate in general. However, in many cases, it is possible to process a suitable combination with rational use of the available anti-TB drugs. Describes the evidence of each drug, this review describes the basis of the recommendations for the treatment of patients with XDR and MDR-TB. The recommended dose is a combination of at least four drugs that could be sensitive to the isolation of M. tuberculosis is high. Efficacy, safety and drug has been selected in the selection step-by-step process in five groups on the basis of cost. Among the first group of high-dose isoniazid (oral medicine in the first row), ethambutol and pyrazinamide is considered as a supplement for the treatment of TB and XDR of MDR. The second group is a fluoroquinolone first in the high-dose levofloxacin as needed. Thereafter, capreomycin, kanamycin, amikacin: third group is an injectable drugs used in the following order. Called second line drugs, then fourth group should be used in order thioamide aminosalicylate cycloserine, below. There are drugs not very effective, and clinical data poor or the target, but the fifth group is included. Drag in the fifth group to be used in the following order: clofazimine amoxicillin, and clavulanic acid, linezolid, carbapenem thioacetazone Clarice then.

A shield with a red cross stopping viruses

      The best way to prevent the emergence of multi-drug resistant strains of bacteria, it is actually very simple: we use antibiotics appropriately. Many people, it is not surprising that with the increase of its availability in particular, it is noted in the excessive use of antibiotics. In fact, a common misconception is that the antibiotic that, in the panacea for all diseases when it is useless against diseases such as colds and flu caused by a virus such they are. Unfortunately, both patients and doctors is contributing to the problem, even if there are no symptoms, doctors are reluctant to prescribe antibiotics in severe patients. Abuse of antibiotics, will be able to limit its effectiveness, but it is the abuse of another problem. Clinical trials and careful study has been performed that the dose of the most effective use of antibiotics in certain types of infections and to provide physicians timing. To follow the instruction of the doctor for without giving the patient the opportunity to develop resistance to antibiotics in bacteria, effectively removing the infection is essential.

      For the prevention of antimicrobial resistance, I have described the drug your doctor is suitable for your condition with you. Never and, please follow the instructions of prescription drugs a doctor strictly, to take, or do not share prescription drugs for someone else. She has a clear understanding of your symptoms or him, antibacterial agents such as antibiotics, such as this, to be able to determine whether it is appropriate, please consult your doctor. Please Do not save antibiotics for the next time you get sick. The taking of medicine instructions of your health care professional you exactly like. Your doctor if you have prescription overdose that were discarded after you have completed the prescribed courses of treatment, the appropriate drug residues. To prevent the disease, healthy habits of lifestyle, including health good proper diet, such as frequent hand washing, such as this, exercise, and sleep patterns, can be used to prevent the abuse of drugs and excessive use.

 GENTAUR Belgium BVBA
 BE0473327336
 Voortstraat 49, 1910 
 Kampenhout BELGIUM
 Tel 0032 16 58 90 45
 Fax 0032 16 50 90 45
 info@gentaur.com
		  
 GENTAUR Ltd. GB111298832
 Howard Frank 
 Turnberry House 
 1404-1410 High Road 
 Whetstone London N20 9BH 
 Tel 020 3393 8531 
 Fax 020 8445 9411
		  
 GENTAUR France SARL
 FR63484237888
 9, rue Lagrange, 75005 Paris
 Tel  01 43 25 01 50 
 Fax 01 43 25 01 60
 RCS Paris B 484 237 888
 SIRET 48423788800017
 RIB 30004 00187 
 00010092253 10
 BNP PARIBAS PARIS PL 
 MAUBERT BIC BNPAFRPPPRG
 IBAN FR76 3000 4001 
 8700 0100 9225 310
 france@gentaur.com
		  
 GENTAUR GmbH 
 DE815175831
 Marienbongard 20
 52062 Aachen Deutschland
 
 de@gentaur.com 
 Tel 0241 95 78 94 78 
 Tacka Vancheva
 Tel logistics 0241 4008 9086 
 Annick Verdeyen
 Fax 0241 55  91 05 36 
 Bankleitzahl 39050000
 IBAN DE8839050000107569353 
 Handelsregister Aachen 
 HRB16058 Steuernummer 
 201/5961/3925 de@gentaur.com
		  
 GENTAUR Nederland BV
 NL850396268B01 Kuiper 1 
 5521 DG Eersel Nederland
 KVK nummer 52327027
 Tel: 0208-080893  
 Fax: 0497-517897
 nl@gentaur.com 
 IBAN: NL04RABO0156985462   
 SWIFT RABONL2U
		  
 GENTAUR Ltd. GB111298832
 Howard Frank 
 Turnberry House 
 1404-1410 High Road 
 Whetstone London N20 9BH 
 Tel 020 3393 8531 
 Fax 020 8445 9411
		  
 GENTAUR U.S.A
 Genprice Inc, Logistics
 547, Yurok Circle
 San Jose, CA 95123
 Phone: (408) 472-2934
 Fax:(408) 416-3994
 Phone (718)513-2983 
 sales@genprice.com
		  
 Genprice Inc, 
 Invoices and accounting
 6017 Snell Ave 
 San Jose, CA 95123
		  
 GENTAUR Italy
 20135 Milano Tel 0236006593 
 Fax 0236006594 
 italia@gentaur.com
		  
 GENTAUR Spain
 tel:0911876558
 spain@gentaur.com
		  
 GENTAUR BULGARIA
 BG20135893153, 
 Graf Ignatiev Str. 
 ent.V, fl. 2 Sofia 1000 
 Tel 0035929830070 
 Fax 0035929830072
 sofia@gentaur.com
		  
 ГЕНТАУЪР БЪЛГАРИЯ
 ID # 201 358 931 
 BULSTAT София 1000
 ул. "Граф Игнатиев" 53 
 вх. В, ет. 2
 Tel  0035929830070 
 Fax 0035929830072
 e-mail: Sofia@gentaur.com 
 IBAN: BG11FINV91501014771636
 BIC: FINVBGSF
		  
 Other countries
 Österreich +43720880899
 Canada Montreal
+15149077481 Ceská republika Praha +420246019719 Danmark +4569918806 Finland Helsset
+358942419041 Magyarország Budapest +3619980547 Ireland Dublin
+35316526556 Luxembourg +35220880274 Norge Oslo +4721031366 Sverige Stockholm
+46852503438 Schweiz Züri +41435006251 US New York +17185132983